Healthcare

Healthcare

Biotech Bill Bundled in Pentagon Spending Plan May Worsen Pharma’s Patent Cliff Dilemma

Photo via Graeme Sloan/Sipa USA/Newscom

The next few years of projected revenues in the pharma space have more holes in them than industry CEOs’ favorite golf courses.

2 min read

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Healthcare

Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments

The company also said earlier this week it will drop $6 billion on a new manufacturing facility in Huntsville, Alabama.

2 min read
Photo via imageBROKER/Joko/Newscom

Healthcare

Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment

The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.

2 min read
Photo via Stacey Wescott/TNS/Newscom

Healthcare

Abbott Breaks into Lucrative Cancer Screening Market with $21 Billion Exact Sciences Purchase

Earlier this month, Exact reported a record $851 million in third-quarter revenue, which included $666 million from its screening business.

2 min read

Healthcare

Johnson & Johnson Buys Prostate Cancer Treatment-Maker Halda for $3.1 Billion

Photo by SiyueSteuber via iStock

J&J this year lost its patent exclusivity for Stelara, its longtime top-selling drug that treats psoriasis and inflammatory bowel disease.

2 min read

M&A

Novo Nordisk’s $10 Billion Bid Ups the Ante in Bidding War for Obesity Biotech Metsera

Photo via Mads Claus Rasmussen/ZUMAPRESS/Newscom

Metsera on Tuesday called Novo Nordisk’s new $10 billion offer “superior” to rival Pfizer’s bid of $8 billion.

2 min read

Healthcare

Novo Nordisk Seeks to Expand Liver Disease Treatments in $5.2B Deal for Bay Area Biotech

Photo via Ritzau Scanpix/Sipa USA/Newscom

The acquisition comes as new CEO Mike Doustdar tries to revive once meteoric growth that has come crashing down to earth this year.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.